Fundz

House Rx Raises $55M in Series B Funding led by New Enterprise Associates and Town Hall Ventures to enhance its specialty pharmacy model.

PRIVATENov 12, 2025

Amount Raised

$55 Million

Round Type

Series B

San FranciscoHealth Care

Investors

First Round CapitalLRVHealthBessemer Venture PartnersTown Hall VenturesSilicon Valley BankNew Enterprise Associates

Description

House Rx, a San Francisco, CA-based health tech company, raised $55M in Series B funding. The round was led by New Enterprise Associates (NEA) and Town Hall Ventures, with participation from other investors. The company plans to use the capital to expand its in-clinic specialty pharmacy model. House Rx has partnered with over 1,000 providers nationwide.

Who to call at House Rx, and when

A new round usually means House Rx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day House Rx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at House Rx, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

House Rx

Location

San Francisco, California, United States

About

House Rx is a technology-enabled service company focused on making specialty medication more accessible and affordable. We do so by helping clinics dispense specialty medications to their patients in a medically-integrated way using pharmacist expertise and modern technology. By helping physicians and pharmacists collaborate on patient care, we’re able to improve patient outcomes, lower the cost of care, and create a better experience for patients and their caregivers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment House Rx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

5 contacts
Verified contactsJason A., VP of Sales hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for House Rx's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

House Rx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.